Respiratory Syncytial Virus Prevention
Clinical research activity is centered on respiratory syncytial virus prevention in early life, with interest in protecting infants during their first year against symptomatic infection and related respiratory illness.
- Maternal RSV immunisation
- Infant RSV prophylaxis
- Seasonal RSV prevention
The sponsor is involved in studies examining strategies that combine protection during pregnancy and infancy to address RSV circulation in the French healthcare setting.
Paediatric Respiratory Infection
Research also covers paediatric respiratory tract infection, with attention to illnesses that affect infants and young children during periods of viral transmission.
- Infant respiratory infection
- Symptomatic viral disease
- Early-life respiratory protection
These interests align with clinical efforts to reduce infection burden in newborns and infants across the first months of life.
Bronchiolitis
The sponsor has a clear focus on bronchiolitis, a key lower respiratory condition in infants that is closely linked to RSV circulation and seasonal respiratory outbreaks.
- Infant bronchiolitis
- Lower respiratory tract disease
- Viral respiratory syndromes
Clinical interest in bronchiolitis reflects concern for preventing severe respiratory manifestations in the youngest patients.
